Update: Shukra Pharmaceuticals Limited will be making the first call for the payment of partly-paid shares. The company has fixed April 14, 2023, as the record date to determine the shareholders of partly-paid shares to whom the first call notice would be sent. You can check the announcement from the company here.
As a result, the partly-paid shares of Shukra Pharmaceuticals Limited (SHUKRAPP) will be suspended from trading on exchanges from April 13, 2023, and you will not be able to see these holdings on Kite.
| Event Schedule | |
|---|---|
| Payment | ₹ 7 per share |
| Call Payment Period | April 24, 2023 - May 8, 2023 |
| Allotment & Listing | Within 2-3 weeks from the last date of payment |
| Amount payable per equity share | Face Value | Premium | Total |
|---|---|---|---|
| On Application | 2.5 | 2.5 | 5 |
| First call | 3.5 | 3.5 | 7 |
| Remaining balance payment to be collected later | 4 | 4 | 8 |
| Total | 10 | 10 | 20 |
How do I make the call payment
You can make call payment via the following modes:
- Netbanking ASBA: Through the website of the SCSB’s.
- Physical ASBA: Submitting a physical application to the Designated Branch of SCSB.
You can check the list of SCSB (Self Certified Syndicate Banks) here.
What will happen if I don’t make the call payment?
If you fail to pay the call money the partly-paid shares may be forfeited (the current Shukra Pharmaceuticals Limited partly-paid shares you hold will be worthless and will not trade on exchanges as the company will allot new shares under different ISIN). The company may also levy interest on the amount you owe.
Shukra Pharmaceuticals Limited (SHUKRAPHAR) has announced a rights issue of 93.9 lakh equity shares aggregating up to Rs. 18.79 crores. The rights issue opens for subscription on February 15, 2023, and will close on February 28, 2023.
Anyone who holds shares of Shukra Pharmaceuticals Limited as of February 02, 2023 (record date) will be eligible for receiving Rights Entitlements (REs). You can check the announcement from the company here.
These REs will be temporarily traded on the stock exchanges and will then be extinguished. You can either use the REs to apply for the rights shares of Shukra Pharmaceuticals Limited or sell them in the market.
You will be eligible for Rights Entitlements (REs) if you have bought the shares on or before February 01, 2023. The ex-date is February 02, 2023.
Rights Issue Details
| Issue Period | February 15, 2023 - February 28, 2023 |
| RE Trading Period | February 15, 2023 - February 23, 2023 |
| RE Symbol | SHUKRA-RE |
| Issue Price | Rs. 20 (Rs. 5 payable on application) |
| Ratio | 6:1 |
| Ex-date | February 02, 2023 |
| Record Date | February 02, 2023 |
| Tentative Date of Allotment for rights shares | March 08, 2023 |
| Tentative Date of Listing for rights shares | March 15, 2023 |
This is a partly-paid issue, meaning at the time of application you only have to make part payment.
| Amount payable per equity share | Face Value | Premium | Total |
|---|---|---|---|
| On Application | 2.5 | 2.5 | 5 |
| One or more additional calls as may be decided by the company | 7.5 | 7.5 | 15 |
| Total | 10 | 10 | 20 |
If you continue holding Shukra Pharmaceuticals Limited partly-paid shares when the company makes a call for the balance payment, you will be liable to pay the balance sum. Alternatively, if you sell the partly-paid shares, the buyer will be liable to pay the sum.
How to apply for Shukra Pharmaceuticals Limited Rights Issue?
Once you either receive the REs from the company or purchase them from the market, you can apply for the rights shares using the below methods;
- Online via Netbanking ASBA
- Offline by submitting the Application Form to the nearest branch of SCSB (Self Certified Syndicate Bank)
You can check the application process here.
You will need to enter your Demat account’s Beneficiary Owner ID which is a 16-digit number while applying for the rights issue.
The option to apply for rights shares through the RTAs portal is not available for this rights issue.
If you face any difficulties applying for the rights issue, you can reach out to the RTA at [email protected] or at 022-23010771 / 49614132.
What will happen to my purchased holding of RE shares if I do not apply for the rights issue?
Your REs will lapse and you will lose the premium paid to acquire them. The RE will be in the form of temporary demat securities which will lapse if not renounced/exercised once the trading window is closed.
I don’t have the shares but bought REs, am I still eligible to apply for the rights issue?
In case you have bought REs but don’t have shares, you’re still eligible for the rights issue. You may apply for the rights shares either through the RTA’s portal or via net banking ASBA if your bank allows it. If you don’t take any action, and let the REs remain in your Zerodha account, they will lapse after the issue.
You can read more FAQ’s on Rights Issue and Rights Entitlements here.